Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Earnings release
confidence 99%
filed 2026-06-18
Item 2.02
This is a clear earnings release for Kroger's first quarter 2026 results, filed on June 18, 2026 under Item 2.02 (Results of Operations and Financial Condition). The press release discloses key financial metrics including identical sales growth of 1.0%, operating profit of $1,407 million, EPS of $1.46, and adjusted EPS of $1.58, along with full-year 2026 guidance reaffirmation. The filing includes consolidated financial statements and detailed reconciliations of non-GAAP measures, which are typical of quarterly earnings disclosures.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-06-18
Item 1.01
Deluxe Corporation entered into a definitive Equity Purchase Agreement and Plan of Merger on June 17, 2026, to acquire Celero Commerce for approximately $625 million in an all-cash transaction funded through $375 million in incremental Term Loan A financing and draws on the existing revolving credit facility. The transaction is expected to close in Q3 2026 and is projected to be accretive to adjusted EPS in the first year with over $15 million in identified cost synergies by 2028.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-18
Item 7.01
TransCode posted a corporate presentation to its website on June 18, 2026, disclosing clinical trial progress (Phase 1a and Phase 2a data for TTX-MC138, Phase 3 status for Seviprotimut-L vaccine), pipeline details, and management/advisory board information. While the presentation contains material clinical and operational information relevant to investors, it does not fit neatly into the standard 8-K event categories (no earnings release, executive change, M&A, restatement, impairment, or other discrete triggering event). The disclosure is furnished under Item 7.01 (Regulation FD Disclosure) as a non-filed investor presentation, making it a material corporate communication that falls outside the more specific taxonomy.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from Cognition Therapeutics' Annual Meeting of Stockholders held on June 17, 2026. The filing reports final vote tallies for two proposals: election of Class II directors (Aaron Fletcher, Ph.D. and Lisa Ricciardi) and ratification of Ernst & Young LLP as independent auditors. The detailed voting counts (For, Against, Withheld, Abstentions, Broker Non-Votes) are the hallmark of Item 5.07 shareholder vote results disclosures, which are material to investors as they confirm governance outcomes and auditor appointment.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-06-18
EX-99.3
Danaos Corporation disclosed its 2025 annual financial results, reporting operating revenues of $1.043 billion, adjusted EBITDA of $719 million, adjusted net income of $486 million, and free cash flow of $608 million, with detailed management commentary on operational performance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from Bicycle Therapeutics' annual general meeting held on June 17, 2026. The filing reports the outcomes of nine proposals including director re-elections (Felix Baker, Hervé Hoppenot), advisory approval of named executive officer compensation, auditor ratification and re-appointment, and approval of remuneration policies. All proposals passed with substantial majorities, as required by Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-06-18
Item 1.01
Janus Henderson entered into a side letter agreement amending its merger agreement with Trian and General Catalyst for a take-private transaction. With regulatory approvals and client consents secured, the transaction is expected to close on June 30, 2026, at $52.00 per share in cash, resulting in the company's delisting from NYSE and conversion to private ownership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-18
Item 5.02
AudioEye's Board approved the appointment of Matthew Domeyer as Chief Financial Officer, effective July 20, 2026. The appointment includes a base salary of $350,000, a signing bonus of $75,000, and equity grants totaling 36,000 stock units.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-06-18
The filing discloses a material antitrust tribunal resolution (RESFC-2026-38-APN) conditioning Telecom Argentina's acquisition of exclusive control over Telefónica Móviles Argentina and its subsidiaries. The resolution imposes significant remedies including divestiture of 6 million mobile customers, spectrum rights, and 211,400 residential internet subscribers across multiple Argentine provinces. This is a conditional approval of a material acquisition that would substantially affect the registrant's competitive position and financial obligations.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-06-18
Item 7.01
Steel Dynamics issued a press release on June 17, 2026 providing second quarter 2026 earnings guidance in the range of $3.51 to $3.55 per diluted share, with detailed forward-looking commentary on segment performance across steel, metals recycling, fabrication, and aluminum operations.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 92%
filed 2026-06-18
Item 5.07
Shareholders approved three proposals at a special meeting: an Extension Amendment to extend the Business Combination deadline from June 24, 2026 to June 24, 2027 (with up to twelve one-month extensions), a Trust Agreement Amendment, and an Adjournment Proposal. All three proposals passed with substantially identical vote tallies (16,621,609 for, 809,296 against, 0 abstentions), and 2,598,697 Class A shares were redeemed for approximately $27.8 million in connection with the Extension Amendment vote.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 92%
filed 2026-06-18
The 6-K discloses results of Grifols' Ordinary General Shareholders' Meeting held on June 18, 2026. The filing reports that shareholders approved most proposals, including dividend distributions (EUR 56.1 million ordinary dividend plus EUR 0.01 per Class B share preferred dividend), re-election of directors, auditor re-election, and capital authorization resolutions. One proposal (Item Eleventh regarding authorization to call extraordinary meetings with 15 days' notice) failed to reach sufficient majority. The disclosure of shareholder voting outcomes on material matters such as dividends, director elections, and capital authorizations is a core shareholder_vote_results event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 73%
filed 2026-06-18
Item 1.01
United Rentals entered into Amendment No. 18 to its Third Amended and Restated Receivables Purchase Agreement on June 18, 2026, extending the expiration date of the accounts receivable securitization facility to June 18, 2027. The amendment creates a direct financial obligation and affects the company's capital structure and liquidity position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-18
Item 5.02
Bank First Corp elected two new directors, Steven M. Eldred (retired CEO of Centre 1 Bancorp) and Todd A. Sprang (retired CPA principal), to its Board effective June 15, 2026, along with the re-election of incumbent Timothy J. McFarlane to a second term, representing a material change in board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
Item 5.07
Bank First Corp held its 2026 Annual Meeting of Shareholders on June 15, 2026, with shareholders voting on four proposals: election of three directors (Eldred, McFarlane, and Sprang), ratification of Forvis Mazars as independent auditor, an advisory vote on named executive officer compensation, and approval of an amendment to the Articles of Incorporation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
Item 5.07
This Item 5.07 filing discloses the results of FS KKR Capital Corp's Annual Meeting of Stockholders held on June 18, 2026, including voting outcomes for director elections (Proposal No. 1), the Share Issuance Proposal (Proposal No. 2, adjourned to August 20, 2026), and the 1940 Act Section 61(a)(4) Issuance Proposal (Proposal No. 3, approved). The filing provides detailed vote tallies for each director nominee and the warrant/options issuance proposal, which are material governance and capital authorization matters affecting shareholders.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-18
Item 1.02
The filing discloses termination of a material definitive agreement for the sale of an 80% undivided tenant-in-common interest in real estate parcels in Paso Robles, California. Although the transaction was terminated rather than completed, the termination of a material acquisition agreement is a reportable M&A event under Item 1.02, and the loss of a significant real estate disposition would materially affect investor assessment of the company's asset base and liquidity plans.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-06-18
Item 2.02
Mesa Royalty Trust issued a press release on June 18, 2026 announcing its royalty income and income distribution for June 2026, which is the core disclosure under Item 2.02. Although the specific announcement is that there will be no distribution for June 2026 due to costs exceeding revenue, this is still a periodic financial results disclosure typical of earnings releases. The material nature is underscored by the reference to accumulated excess production costs and the expectation that distributions will be materially reduced until cash reserves reach $2.0 million, signaling financial stress for the trust.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 75%
filed 2026-06-18
EX-99.1
Alibaba announced adjustments to the conversion rates of its convertible senior notes due 2031 and zero coupon convertible senior notes due 2032, both triggered by the declaration of an annual dividend of US$0.13125 per ordinary share. The adjustments increased the conversion rates and the maximum number of ordinary shares issuable upon full conversion, materially affecting the dilutive potential of these outstanding debt instruments.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
MultiSensor AI Holdings held its Annual Meeting on June 12, 2026, with shareholders voting on three proposals: election of five directors (Margaret Chu, Stuart Flavin III, Daniel Friedberg, David Gow, and Petros Kitsos), ratification of Weaver and Tidwell L.L.P. as independent auditor, and approval of an amendment to the 2023 Incentive Award Plan increasing authorized shares by 500,000 to 661,012 total shares. All three proposals passed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This 8-K Item 5.07 discloses the results of Structure Therapeutics' 2026 Annual General Meeting of Shareholders held on June 17, 2026, including voting outcomes for three proposals: election of three Class III directors (Ted W. Love, M.D., Raymond Stevens, Ph.D., and Daniel G. Welch), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The disclosure of shareholder vote results at an annual meeting is a material event affecting investor understanding of corporate governance and board composition.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-06-18
Item 1.01
Vireo Growth Inc. entered into a definitive arrangement agreement on June 14, 2026, to acquire all issued and outstanding common shares of C21 Investments Inc. in exchange for 0.023052 subordinate voting shares of Vireo per C21 share. The transaction, subject to shareholder approval, court orders, and regulatory approvals, is expected to expand Vireo's Nevada operations to approximately 15 dispensaries and 158,000 square feet of cultivation and manufacturing capacity.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Ironwood Pharmaceuticals held its Annual Meeting of Stockholders and disclosed voting results on multiple matters, including election of eight directors, advisory approval of named executive officer compensation, approval of a Plan Amendment increasing equity incentive plan shares by 10 million, and ratification of KPMG LLP as independent auditor.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-18
Item 3.02
PTC Therapeutics completed a $550 million private placement of convertible senior notes with an initial conversion price of approximately $107.48 per share, sold to qualified institutional buyers under Section 4(a)(2) and Rule 144A. The company does not intend to register the resale of the notes or conversion shares, creating significant dilution potential to common shareholders. Net proceeds of $328.8 million are being used to repurchase $222.0 million in aggregate principal of existing convertible notes and for general corporate purposes.
View raw filing on EDGAR →
8-K
M&A activity
confidence 60%
filed 2026-06-18
Item 2.03
Item 2.03 incorporates Item 1.01 by reference, indicating a material transaction that creates direct financial obligations consistent with M&A activity classification.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-18
Item 8.01
The filing discloses the full exercise of an over-allotment option on June 18, 2026, resulting in the sale of 116,667 additional shares of common stock at $4.33 per share for net proceeds of approximately $470,858. This represents a dilutive equity issuance that increases the company's share count and is material to investors assessing ownership dilution and capital structure changes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting held on June 17, 2026, covering four proposals: election of six directors, ratification of Grant Thornton LLP as auditor, Say-on-Pay advisory vote, and approval of the Sixth Amended and Restated 2010 Equity Incentive Plan. The filing presents detailed vote tallies (FOR, AGAINST, ABSTAIN, and broker non-votes) for each proposal, which is the hallmark of Item 5.07 shareholder vote results disclosures and is material to investors assessing board composition and governance matters.
View raw filing on EDGAR →
8-K
Other material
confidence 71%
filed 2026-06-18
Item 1.01
BrightView extended the maturity of its senior secured term loans from April 2029 to June 2033 (Amendment No. 11 to Credit Agreement) and its receivables financing facility from June 2027 to June 2029 (Sixth Amendment to Receivables Financing Agreement). These refinancings strengthen the company's balance sheet by extending its debt maturity profile and providing additional liquidity runway.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-06-18
Item 2.02
This is a press release announcing the Trust's monthly cash distribution of $0.017000 per unit payable July 15, 2026, along with detailed financial and operational metrics including oil/gas sales volumes, realized wellhead prices, cash receipts, and operating expenses. The disclosure includes specific production data (31,005 barrels of oil, 548,911 Mcf of natural gas) and pricing information ($82.93/Bbl oil, $4.74/Mcf gas), which are core financial results for a royalty trust. This is material to unitholders as it directly affects the periodic distributions they receive.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-18
Item 1.01
Epsilon Energy entered into an at-the-market (ATM) sales agreement with Roth Capital Partners authorizing the sale of up to $15 million in common shares. This is a dilutive equity issuance mechanism that allows the company to raise capital through registered offerings at prevailing market prices. The material nature of the $15 million authorization and the equity dilution to existing shareholders makes this a significant capital-raising event that would affect investor assessment of the company's financing strategy and shareholder ownership.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Tidewater held its Annual Meeting of Stockholders on June 16, 2026, with 89.57% attendance. Stockholders approved all four proposals: election of seven directors, advisory vote on executive compensation, amendment to the 2021 Stock Incentive Plan increasing available shares by 2,250,000, and ratification of PricewaterhouseCoopers LLP as auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This Item 5.07 disclosure presents the complete voting results from BJ's Wholesale Club's annual meeting of shareholders held on June 18, 2026, covering seven distinct proposals: election of ten directors, advisory vote on named executive officer compensation, frequency of future compensation votes, ratification of PricewaterhouseCoopers LLP as independent auditor, and shareholder proposals on majority voting and environmental reporting. The filing explicitly states voting tallies (FOR, AGAINST, WITHHELD, ABSTAINED, BROKER NON-VOTES) for each proposal, which is the core content of a shareholder_vote_results disclosure under Item 5.07.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 85%
filed 2026-06-18
EX-99.1
NetClass Technology Inc. has entered into a Technical Development Service Agreement with Bangyuan Liu to issue 2,800,000 ordinary shares as consideration for software development services over a one-year engagement, with issuance required by May 31, 2026.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 85%
filed 2026-06-18
EX-99.2
NetClass Technology Inc. has agreed to issue 3,200,000 Class A ordinary shares to Akaewood Investment Holding Co., Ltd. as consideration for AI-based technology R&D services over a 12-month term.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder vote results from the Annual Meeting of Stockholders held on June 16, 2026, covering five proposals: director elections (Proposal 1), auditor ratification (Proposal 2), equity plan amendment (Proposal 3), executive compensation advisory vote (Proposal 4), and meeting adjournment (Proposal 5). The filing presents voting tallies for each proposal, which is the core content of Item 5.07 disclosures. Director elections and equity plan amendments are material to investors' assessment of governance and capital structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Protagonist Therapeutics held an Annual Meeting of Stockholders at which shareholders voted on four proposals: election of two Class I directors (Dinesh V. Patel and Lewis T. Williams), an advisory vote on named executive officer compensation, ratification of Ernst & Young LLP as the independent auditor, and approval of the 2026 Equity Incentive Plan. Final voting results for all four proposals are disclosed.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-18
Item 3.02
KKR FS Income Trust issued 2,785,366.442 Class I shares for approximately $81.276 million in an unregistered private offering under Section 4(a)(2) and Regulation D to accredited investors, diluting existing shareholder ownership.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 8.01
The Company disclosed its net asset value per share of $29.18 as of May 31, 2026 (aggregate NAV of $1.589 billion) and reported that its ongoing private offering has raised $1.748 billion of a $5.0 billion target, providing investors with current valuation and offering progress metrics.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-18
Item 3.02
Graf Global Corp. issued Class A Ordinary Shares upon conversion of Class B Ordinary Shares, relying on Section 3(a)(9) exemption from Securities Act registration. The Sponsor and three board members irrevocably converted 5,749,999 Class B shares into Class A shares on a one-for-one basis, reducing Class B shares outstanding from 5,750,000 to 1, representing a material change in capital structure and shareholder voting/economic rights.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-18
Item 3.02
KKR FS Income Trust Select issued 183,883.440 Class I shares for approximately $4.597 million pursuant to a continuous private offering under Section 4(a)(2) and Regulation D to accredited investors.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Willdan Group held its Annual Meeting of Stockholders on June 17, 2026, with detailed voting results disclosed for all four proposals: director elections, auditor ratification, advisory compensation vote, and amendments to the 2008 Performance Incentive Plan.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-18
Item 5.02
The Board approved and stockholders ratified amendments to the Willdan Group 2008 Performance Incentive Plan, including a 380,000-share increase in available awards and extension of the plan term to 2036, materially affecting future dilution and executive compensation capacity.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This Item 5.07 disclosure reports the results of Elauwit Connection's annual meeting of stockholders held on June 18, 2026, including voting outcomes for three proposals: election of three directors (Leslie Goodman, David O'Brien, and Barry Rubens), ratification of WithumSmith+Brown, PC as independent auditor, and approval of an adjournment proposal. The detailed vote tallies (FOR, AGAINST, WITHHELD, ABSTAIN, and broker non-votes) are the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-18
Item 1.01
Yorkville International Capital Corp. completed its initial public offering on June 17, 2026, issuing 23 million units at $10.00 per unit for $230 million in gross proceeds. The IPO involved entry into multiple material agreements including the Underwriting Agreement, Warrant Agreement, Investment Management Trust Agreement, and Registration Rights Agreement, representing a material capital-raising event and change of control for the blank-check company.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-18
Item 3.02
Simultaneously with the IPO closing, Yorkville issued 6,300,000 unregistered warrants (4,000,000 to the Sponsor and 2,300,000 to CCM) at $1.00 per warrant pursuant to Section 4(a)(2) exemption, materially diluting existing and new shareholders' ownership interests.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-18
Item 5.02
Four new directors—Kevin McGurn, Owen A. May, Mark Hiltwein, and John-Paul Colaco—were appointed to the board in connection with the company's IPO on June 16, 2026, with assignments to various board committees.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 5.03
Yorkville filed amended and restated memorandum and articles of association in connection with its IPO, implementing corporate governance amendments required for the company's transition to a publicly traded blank-check SPAC.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Zura Bio held its Annual Meeting of Shareholders on June 17, 2026, with voting results on four proposals: election of eight directors, ratification of WithumSmith+Brown, PC as independent auditor, approval of the Amended 2023 Equity Incentive Plan, and an adjournment proposal. Detailed vote tallies (For/Against/Abstain/Broker Non-Votes) for each proposal are disclosed.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-18
Item 1.01
Ford Credit Auto Receivables Two LLC (the Depositor) entered into an Underwriting Agreement on June 16, 2026 for the issuance of asset-backed securities by Ford Credit Auto Owner Trust 2026-B, involving the disposition of auto receivables and securitization of those assets.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-18
EX-99.1
This press release announces final results from a Grade Control drilling program at Mayfair's Fenn-Gib Project, validating the mineral reserve model and confirming ore-grade material characteristics. The disclosure is material to investors as it de-risks the project by confirming reserve estimates, validates early-years high-grade feed availability, and supports project financing discussions—all critical milestones for a development-stage gold company advancing toward 2028 construction. However, it does not fit neatly into standard event categories (not earnings, M&A, impairment, or litigation), making it an operational/strategic milestone best classified as operational_other.
View raw filing on EDGAR →